Conference Registration, Conference Materials Pick-Up, Morning Coffee and Breakfast Pastries

Coffee Break and Networking

Networking Lunch in the Exhibit Hall: Visit Exhibitors and Poster Viewing

Jet-based Bioprinting: Implementation, Process Dynamics, and Process-Induced Cell Injury
Yong Huang, Professor, University of Florida, United States of America

Maskless jet-based (including laser- and inkjet-based) three-dimensional (3D) cell bioprinting is a revolutionary advance for printing arbitrary cell patterns as well as creating heterogeneous living constructs. Unfortunately, process-induced thermomechanical injury to cells as well as other biomaterials during printing still poses a significant challenge to ensuring satisfactory post-transfer cell viability. Using a representative laser bioprinting technology (laser-induced forward transfer) as a jet-based model system, we have been addressing the aforementioned printing-induced cell injury challenge by studying the process-induced cell thermomechanical loading during the cell droplet formation and landing processes and the post-transfer cell viability based on the process-induced thermomechanical loading. In this talk, the perspective of ongoing bioprinting research is first introduced. Then the modeling of the laser-induced cellular droplet formation and landing processes is discussed. The relationship between the mechanical loading information and the post-transfer cell injury/viability is further established through an apoptosis signaling pathway-based modeling approach. Finally, this talk shares some thoughts regarding basic scientific challenges during bioprinting.

Technology Spotlight:
Development of Bioinks for 3D Bioprinting of Soft Tissues
Hector Martínez, Chief Technology Officer, CELLINK

3D Bioprinting has gained attention in tissue engineering due to its ability to spatially control the placement of cells, biomaterials and biological molecules. The development of new hydrogel bioinks with good printability and bioactive properties has made it possible to 3D bioprint and accelerate the maturation of complex 3D tissue-like models. In this talk, we present our recent bioink development for different tissue engineering applications, such as brain, skin and bone tissues.

3D Bioprinting and Perfusion of Vascularized Tissues
David Kolesky, Research Scientist, Harvard University and The Wyss Institute for Bioloigcally Inspired Engineering, United States of America

Engineered thick living tissue constructs could enable new in vitro applications in 3D cell studies, drug screening, disease modeling, and, ultimately, therapeutic applications in regenerative medicine. We will highlight our recent efforts on concurrent patterning of cells and vasculature, along with new strategies to achieve active perfusion, long-term stability of thick living tissues (> 1cm thick), all of which are essential for creating a physiologically and therapeutically relevant tissue manufacturing method.  As a demonstration of complex architecture and function at a physiologically relevant size scales, we directly differentiate patterned hBM-MSCs towards the osteogenic lineage via the in situ delivery of various factors through a pervasive vascular network, illustrating control over the long-term growth and development of our printed tissue. With control over multicellular architecture, the chemo-mechanical microenvironment, and the ability to support thick, developing tissue for long time points, this method could serve as a platform for studying emergent biological functions in complex engineered micro-environments, and, may ultimately, find applications in vivo.

3D Printing Functional Materials & Devices
Michael McAlpine, Kuhrmeyer Family Chair Professor of Mechanical Engineering, University of Minnesota, United States of America

The development of methods for interfacing high performance functional devices with biology could impact regenerative medicine, smart prosthetics, and human-machine interfaces. Indeed, the ability to three-dimensionally interweave biological and functional materials could enable the creation of devices possessing unique geometries, properties, and functionalities. Yet, most high quality functional materials are two dimensional, hard and brittle, and require high crystallization temperatures for maximal performance. These properties render the corresponding devices incompatible with biology, which is three-dimensional, soft, stretchable, and temperature sensitive. We overcome these dichotomies by: 1) using 3D printing and scanning for customized, interwoven, anatomically accurate device architectures; 2) employing nanotechnology as an enabling route for overcoming mechanical discrepancies while retaining high performance; and 3) 3D printing a range of soft and nanoscale materials to enable the integration of a diverse palette of high quality functional nanomaterials with biology. 3D printing is a multi-scale platform, allowing for the incorporation of functional nanoscale inks, the printing of microscale features, and ultimately the creation of macroscale devices. This three-dimensional blending of functional materials and ‘living’ platforms may enable next-generation 3D printed devices.

Networking Reception with Beer, Wine and Appetizers. Engage with Fellow Delegates and Enjoy Views of the Charles River and the Boston Skyline

Clase of Day 1 of the Conference

Dinner Short Course on Biofabrication, 3D-Printing & Microfluidics [Separate Registration Required]

Morning Coffee, Breakfast Pastries and Networking in the Exhibit Hall

Breakfast IP Briefing: The Intellectual Property Landscape of 3D-Bioprinting
Deborah Sterling, Director, Sterne, Kessler, Goldstein & Fox PLLC, United States of America
Stephanie Elmer, Associate, Sterne, Kessler, Goldstein & Fox PLLC, United States of America

A company seeking to make, use, or sell bioprinted organs and tissues must consider the patent landscape.  This talk will focus on ways to protect bioprinted organs and tissues, patent filings directed to bioprinted organs and tissues, certain exceptions to patent infringement, as well as the possibility of future litigation.

Scaffold-Free Biofabrication with the ‘Regenova Bio 3D Printer’
Nicanor Moldovan, Associate Research Professor, Departments of Biomedical Engineering and Ophthalmology, Indiana University-Purdue University Indianapolis, United States of America

Bioprinting is one of the most advanced forms of biofabrication. ‘Scaffold-free’ bioprinting relies only on the cells’ ability to reconstitute complex bio-similar tissues, without the need of an artificial material as bioprinting support (or ‘scaffold’). I will illustrate this concept with the case of ‘Regenova Bio 3D Printer’, commercialized in Japan by Cyfuse Biomedical K.K., and in US by its subsidiary Amuza, Inc. This technology is now available in our recently-established 3D Bioprinting Core facility that serves the researchers at our University and in Midwest USA.

Cardiovascular Tissue Engineering using 3D Printing Technology
Narutoshi Hibino, Assistant Professor, Cardiac Surgery, Johns Hopkins Hospital, United States of America

Cardiovascular disease is one of the leading causes of death worldwide despite the variety of medical, mechanical, and surgical strategies. We have developed novel 3D printing technologies that could change the practice of cardiovascular disease treatment, including patient specific 3D printed tissue engineered vascular graft and bio 3D printed cardiac tissue. I will discuss insights of these new 3D printing technology as well as challenges we need to overcome for future clinical application and commercialization.

Recent Advances in Micro-Liver Tissue Engineering
Berk Usta, Instructor in Surgery, Massachusetts General Hospital – Harvard Medical School – Shriners Hospitals for Children, United States of America

The liver performs many key functions such as serving as the metabolic hub of the body. Accordingly, the liver is the focal point of many investigations aimed at understanding an organism’s toxicological response to endogenous and exogenous challenges.  In this talk, I will review the recent advances in micro-tissue engineering by other groups and then focus on our own work at the Center for Engineering in Medicine at the Massachusetts General Hospital. Main subject areas will be our work on producing viable micro human/rat liver models, alternative biomaterials for micro-tissue engineering and finally our recent efforts towards recapitulation of physiological zonation of the liver.

Stimuli-Responsive Biomaterials for 3D Printing
Rachael Oldinski, Assistant Professor, Department of Mechanical Engineering, University of Vermont, United States of America

The development of stimuli-responsive, or ‘smart’ biomaterials is critical to the manipulative manufacturing of custom tissue engineering scaffolds and implants. This talk will focus on the modification of a seaweed derivative, alginate, for the design of sustainable materials for tissue engineering construct development using 3D printing technology.

Coffee Break and Networking in the Exhibit Hall: Visit Exhibitors and Poster Viewing

Tissue Engineered Microenvironments For Studying Human Tumor Metastasis
Jungwoo Lee, Assistant Professor, University of Massachusetts-Amherst, United States of America

Disseminated tumor cells (DTCs) undergo varying periods of dormancy in ectopic tissue sites before developing overt metastatic tumors. Accumulating evidence suggests that metastatic dormancy and recurrence of DTCs is regulated by intrinsic genetic instability and close interaction with the surrounding microenvironment. Yet, the mechanism by which DTCs enter and escape dormancy remains largely uncertain due to the lack of model systems that can capture the initial activity of extremely rare DTCs. Here, we introduce a bioengineered approach to capture the critical events regulated by the extrinsic tissue microenvironments on DTCs with high experimental control and fidelity. We first developed human soluble factor enriched and vascularized microenvironments by subdermally implanting human bone marrow stromal cell preseeded scaffolds into immunodeficient NSG mice. Humanized tissue analogues recruited circulating human tumor cells released from physiologically relevant orthotopic xenograft tumors. Tail-vein delivery of human peripheral blood mononuclear cells further increased cellular complexity. Established human stromal-tumor-immune niches were serially transplanted into naïve NSG mice for continuous monitoring of metastatic tumor development. Our approach successfully recapitulated the heterogeneous phenotypes, dormant and aggressive, of DTCs and demonstrated human stromal and immune cell derived niche regulation.

Beyond Tissue Printing: Liquid Like Solids Support 3D Cell Science and Engineering
Thomas Angelini, Professor, Department of Mechanical and Aerospace Engineering, University of Florida, United States of America

Throughout the broad areas of tissue engineering, cellular therapeutics, and personalized medicine, there is an immediate need for research platforms with the facility and versatility of cell culture that rival or surpass the effectiveness of animal models, allowing biochemical, environmental, and mechanical parameters to be tuned precisely for each tissue, disease, patient and test condition. In this presentation I will describe a recently developed three-dimensional microenvironment for cell culture, as well as a 3D printing technique for creating micro-tissues within this 3D growth medium. The method leverages the fluid-solid jamming transition within liquid-like solids, which allows robotically controlled nozzles to create cellular structures, deposit molecules, and exchange fluids directly to suspended cell populations. This system enables the large scale, rapid generation of micro-tissues of reproducible size and geometry with access to nutrients or exogenously added bioactive molecules through unrestricted diffusion. This research is the focus of an ongoing collaboration between multiple laboratories from the college of engineering and the college of medicine at the University of Florida. The ultimate goal is to discover the chemical and physical environmental conditions necessary to create in vitro replicas of in vivo tissue groups for high-throughput drug screening, and implantation for tissue therapy or repair.

Networking Lunch in the Exhibit Hall: Visit Exhibitors and Engage with Your Fellow Delegates

Luncheon Presentation: 3D Tissue Printing for Clinical Cardiovascular Applications
Jonathan Butcher, Associate Professor, Biomedical Engineering, Cornell University, United States of America

3D Bioprinting of GelMA Scaffolds Triggers Mineral Deposition by Primary Human Osteoblasts
Christine McBeth, Senior Research Scientist, Fraunhofer Center for Manufacturing Innovation, United States of America

We discuss our bioprinter that can generate osseoinductive structures that are directly grafted to implants destined for orthopedic applications. We further describe our novel hybrid bioinks that are specifically designed to meet both the demands of bioprinting and downstream applications.

Toward Building Complex Biomaterial Matrix Microenvironments by Low-Voltage Continuous Electrospinning Patterning
Yan Yan Shery Huang, Professor of BioEngineering, University of Cambridge, United Kingdom

The creation of more complex tissue models in vitro points to the need for controlled assembly of artificial and biological material architectures in two dimensional (2D) and three dimensional (3D) space. Existing biomaterial fabrication techniques (e.g., 3D printing, electrospinning, and templating) fall short in building the complex combinations of chemical and structural elements, with limited feature resolution. Our recent development in low-voltage electrospinning patterning (LEP), and its combination with additive manufacturing, opens up new avenues in the creation of geometrically defined biomaterial matrices. This presentation will demonstrate LEP’s applications in fabricating bio-scaffolds, single-fibres with multi-scale morphologies, and the printing of microelectrodes onto flexible substrates.

Perfusion Directed 3D-Bone Mineralization
Pranav Soman, Associate Professor, Biomedical and Chemical Engineering, Syracuse University, United States of America

An inherent challenge in conventional tissue engineering strategies is the ability to efficiently deliver nutrients throughout the thickness of a complex, physiologically relevant biomimetic construct. In lieu of adequate interstitial perfusion, cellular viability and physiological function is compromised. In this work, we will present the creation of structurally supported, perfusable hydrogels capable of growing bone in user defined directions. Briefly, bone-like human osteosarcoma cells were encapsulated inside UV cross-linkable gelatin methacrylate (GelMA) hydrogels, and this cell-hydrogel mixture was casted onto a 3D printed poly(vinyl alcohol) (PVA) structure. PVA serves as a sacrificial material and was dissolved away to obtain hollow channels to facilitate the perfusion of media using a custom-made acrylonitrile butadiene styrene (ABS) bioreactor. Osteogenic media was perfused through the channels, and the radial zones of bone mineralization surrounding the channels were quantified.  This study demonstrates that user-defined 3D printed channels can be used to spatially control bone mineralization.

Modification of Bacterial Nano-cellulose with IKVAV Peptide for Tissue Engineering Applications
Luismar Porto, Associate Professor, Federal University of Santa Catarina (UFSC) Brazil , Brazil

The fabrication of suitable porous polymer scaffolds which mimic natural tissues is still one of the main challenges of tissue engineering. Bacterial nanocellulose (BNC) hydrogels possesses a nanofiber network that resembles the native extracellular matrix. The immobilization of bioactive molecules into its microstructure may add functionality and improves support for adhesion and proliferation of human cells. The main goal of this work was the functionalization of BNC hydrogel membrane with IKVAV peptide (BHMI) to enhance the biomaterial. BNC membranes were produced by Gluconacetobacter hansenii. BHMIs were prepared by oxidation reaction of BNC followed by chemical derivatization with EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide) and functionalization with IKVAV. Scanning electron microscopy imaging of BNC before oxidation showed a clear 3D nanofiber network structure; after IKVAV immobilization, granules of the peptide were formed on the nanofiber surface. Functionalization was confirmed by Fourier Transformed Infrared Spectroscopy. Human umbilical endothelial cells (HUVECs) were aseptically seeded on BHMI and, after 48 hours, the functionalized scaffold was able to promote HUVEC adhesion and proliferation. Cell alignment, spreading and endothelial tube organization was also observed. Our results showed that BNC-IKVAV hydrogels supports tubulogenesis in vitro showing that they are a very versatile biomaterial.

Harnessing the Inflammatory Response for Tissue Regeneration
Kara Spiller, Assistant Professor, Drexel University, United States of America

The inflammatory response plays a major role in the body’s response to injury, disease, or implantation of a biomaterial. When the inflammatory response functions normally, it can be a powerful force that promotes tissue repair and regeneration, but when it goes awry, disease takes hold and healing is impaired. The goal of the Biomaterials and Regenerative Medicine Laboratory at Drexel University is to understand the mechanisms by which the inflammatory response orchestrates successful tissue regeneration and to develop novel biomaterial strategies that apply these principles to situations in which tissue regeneration is impaired. In particular, we focus on the behavior of the macrophage, which can rapidly change behavior in response to environmental stimuli to promote inflammation (M1), tissue deposition (M2a), or remodeling (M2c). Through their dynamic phenotypic changes, macrophages function as major regulators of healing. Current emphasis is on tracking macrophage phenotype changes in the healing (or lack thereof) of human chronic diabetic foot ulcers, which holds potential to allow a personalized medicine approach to wound care. We will also discuss novel drug delivery strategies that harness macrophage behavior to promote tissue regeneration and healing in a diverse array of tissues.

3D Printing of Patient-Specific Brain Cancer Model
Hee-Gyeong Yi, Researcher, Pohang University of Science and Technology, Korea, Korea South

Demand for a patient-specific cancer model is critical to predicting the valuable clinical benefit of new drug combinations for personalized medicine. Since there are large numbers of drug candidates, the test solely relying on animals requires the prohibitively expensive and time-consuming procedures. Although the ex vivo cancer models are favorable to conduct high-throughput screening, their translational applications have been hindered by the inability to reflect the tumor micro-environment including three-dimensional (3D) extracellular matrix (ECM) and the cancer-associated cells. A challenge is to simultaneously mimic the dimensionality, complexity, and heterogeneity of the original environment. Here, we describe 3D printing technology for generating a highly biomimetic platform that replicates the heterogeneous tumor micro-environment and thereby can be a patient-specific model of human brain cancer. Our approach is demonstrated to have a promise to replicate the patient's brain cancer. We expect that our approach is probably applicable to other cancers.

Engineering Lungs for Transplantation: Harnessing the Regenerative Potential of Human Airway Stem Cells
Sarah Gilpin, Massachusetts General Hospital (MGH), Harvard Medical School, Instructor, Department of Surgery, United States of America

This presentation will discuss our progress toward bioengineering transplantable human lungs, and describe the use of tissue-derived airway stem cells for ex vivo lung regeneration.

Origami-Enabled Tissue Engineering
Carol Livermore, Associate Professor, Department of Mechanical and Industrial Engineering, Northeastern University, United States of America

Replicating liver structure in engineered tissue is challenging because of liver’s dependence on the effective diffusion of nutrients and metabolic byproducts and because of the massive parallelism of its fine structure.  Origami-based microfluidics offers a new paradigm for addressing these challenges. Folding offers a low-cost, rapid means of creating larger scale fluidic structure to mimic vasculature; co-folding of porous and nonporous materials permits diffusion between hepatocytes and “engineered sinusoids”; and directed cell assembly offers control of cell organization at smaller length scales for the creation of hierarchical architectures. This talk will present the enabling tools of origami tissue engineering and their demonstration through the design, fabrication, and biological characterization of origami liver tissue units.

Close of Day 2 of the Conference.